Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

4,720 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Progressive Site-Directed Therapy for Castration-Resistant Prostate Cancer: Localization of the Progressive Site as a Prognostic Factor.
Yoshida S, Takahara T, Arita Y, Ishii C, Uchida Y, Nakagawa K, Toda K, Sakamoto T, Kijima T, Yokoyama M, Ishioka J, Matsuoka Y, Saito K, Yoshimura R, Fujii Y. Yoshida S, et al. Among authors: nakagawa k. Int J Radiat Oncol Biol Phys. 2019 Oct 1;105(2):376-381. doi: 10.1016/j.ijrobp.2019.06.011. Epub 2019 Jun 12. Int J Radiat Oncol Biol Phys. 2019. PMID: 31201896
CT-Guided Pelvic Lymph Nodal Brachytherapy.
Kunogi H, Hsu IC, Yamaguchi N, Kusunoki S, Nakagawa K, Sugimori Y, Fujino K, Terao Y, Ogishima D, Yoshimura R, Sasai K. Kunogi H, et al. Among authors: nakagawa k. Front Oncol. 2021 Feb 19;10:532555. doi: 10.3389/fonc.2020.532555. eCollection 2020. Front Oncol. 2021. PMID: 33680907 Free PMC article.
Corrigendum to "A phase II study (WJOG12819L) to assess the efficacy of osimertinib in patients with EGFR mutation-positive NSCLC in whom systemic disease (T790M-negative) progressed after treatment with first- or second-generation EGFR TKI and platinum-based chemotherapy" [Lung Cancer 177 (2023) 44-50].
Takeda M, Shimokawa M, Nakamura A, Nosaki K, Watanabe Y, Kato T, Hayakawa D, Tanaka H, Takahashi T, Oki M, Tachihara M, Fujimoto D, Hayashi H, Yamaguchi K, Yamamoto S, Iwama E, Azuma K, Hasegawa K, Yamamoto N, Nakagawa K. Takeda M, et al. Among authors: nakagawa k. Lung Cancer. 2024 Jun 17:107852. doi: 10.1016/j.lungcan.2024.107852. Online ahead of print. Lung Cancer. 2024. PMID: 38890056 No abstract available.
4,720 results